Skip to content

Effects of Inhalation of Entonox and Parentral Morphine Sulfate in Patients with Renal Colic

Analgesic Effects of Inhalation of Entonox and Parentral Morphine Sulfate in Patients with Renal Colic; A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014120215620N4
Enrollment
100
Registered
2015-05-11
Start date
2012-12-29
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Colic. Calculus of kidney and ureter

Interventions

Intervention 1: Group 1: Parenteral morphine sulfate (0.1 mg/Kg) + 100 mg Diclofenac (suppository). Intervention 2: Group 2: 30 minutes of mask ventilation with Entonox (50% nitric oxide) + 100 mg Dic
Treatment - Drugs
Group 1: Parenteral morphine sulfate (0.1 mg/Kg) + 100 mg Diclofenac (suppository)
Group 2: 30 minutes of mask ventilation with Entonox (50% nitric oxide) + 100 mg Diclofenac (suppository)

Sponsors

Vice Chancellor of Research, Shahid Beheshti Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 20-50 years; acute renal colic conformed by both ultrasonography and abdominopelvic CT-Scan Exclusion criteria: Pregnancy; asthma; chronic pulmonary obstructive disease (COPD); intestinal obstruction; hypertension; congestive heart failure; a history of surgery on kidneys and the urinary tract; peptic ulcers and gastrointestinal hemorrhage; allergy to aspirin, NSAIDs and morphine; decreased level of consciousness, head and thoracic trauma; pneumocephalus; pneumothorax (or entrapment of air in any part of the body); drug abuse; tenderness and rebound tenderness, abdominal guarding; delayed menstruation; use of any analgesic during the previous 24 hours and at entry into the emergency ward

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: 3, 5, 10, 30, 120 minutes after intervention. Method of measurement: Visual analogue scale.

Secondary

MeasureTime frame
?Drug side effects. Timepoint: 3, 5, 10, 30, 120 minutes after intervention. Method of measurement: Examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZein Alabedin Chaboksavar

Shahid Beheshti Medical University

Zchaboksavar@yahoo.com+98 21 2240 0207

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026